5 takeaways from J&J’s investor day

The company outlined its long-term growth expectations and confirmed that it has no plans to separate its medtech and pharma segments.

By Elise Reuter • Dec. 6, 2023

US hospitals forecast 9% capex growth to support elective procedure backlog: survey

The Baird survey of 38 health system CFOs forecasts that hospital capital spending growth in 2024 will slow from a 13% jump this year.

By Nick Paul Taylor • Dec. 6, 2023

Explore the Trendline➔

Top 5 stories from MedTech Dive

From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

J&J hernia mesh settlement prompts judge to dismiss more than 200 cases

The company and claimants in Georgia filed to dismiss cases related to Ethicon’s Physiomesh in late November. 

By Nick Paul Taylor • Dec. 6, 2023

Intuitive’s venture capital arm launches second investment fund

The $150 million fund will back early-stage companies focused on healthcare access, digital health, and precision diagnostics and interventions.

By Susan Kelly • Dec. 5, 2023

Laboratory trade group, providers oppose FDA’s lab developed test proposal

A CDRH spokesperson confirmed to MedTech Dive that a discrepancy in the submission system used for the proposed rule led to an initial overcount of public comments.

By Nick Paul Taylor • Updated Dec. 7, 2023

Baxter sends another safety notice about syringe infusion pump errors

The company shared “reinforced guidance” to mitigate the risk of underdosing and interruptions to treatment.

By Nick Paul Taylor • Updated Dec. 6, 2023

Nevro buys low back pain company Vyrsa for $40M

The company expects the acquisition to be revenue accretive starting in 2024.

By Elise Reuter • Dec. 4, 2023

Resmed’s new C-suite focused on growing sleep apnea device demand: analysts

After gaining market share during the Philips recall, Resmed can keep growing by stimulating demand through marketing initiatives and new products, William Blair analysts wrote.

By Nick Paul Taylor • Dec. 4, 2023

BD tells customers not to use Cardinal’s Monoject syringes with Alaris pumps

The FDA labeled BD's safety notice as a Class I event. The warning comes amid several actions from the agency on the safety of syringes.

By Nick Paul Taylor • Dec. 4, 2023

Empatica aims to develop seizure-forecasting algorithm based on wearable data

The company plans a study using its wrist-worn device to capture real-world data that could help understand and predict seizures for people with epilepsy.

By Nick Paul Taylor • Dec. 1, 2023

GE HealthCare, Hologic put AI at center of radiology pitches

BTIG analysts said GE HealthCare believes AI can help clinicians and radiologists do their jobs better, which is important due to the “ongoing shortage of radiologists and the high rates of burn out.”

By Nick Paul Taylor • Dec. 1, 2023

Moon Surgical CEO Anne Osdoit on readying a soft tissue robot for launch

With support from J&J’s venture capital arm and chip maker Nvidia, Moon is targeting a soft tissue surgery market dominated by Intuitive Surgical.

By Susan Kelly • Dec. 1, 2023

FDA advises against using plastic syringes made in China amid reports of quality failures

Officials began the investigation after receiving information about quality issues associated with “several Chinese manufacturers of syringes.”

By Nick Paul Taylor • Dec. 1, 2023

J&J heats up LAA closure competition with $400M Laminar buy

Just days after Medtronic announced it would launch a LAA device, J&J said it has acquired a company that is developing a new treatment for LAA closure.

By Susan Kelly • Nov. 30, 2023

Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea

The clearance positions the company to offer an alternative to continuous positive airway pressure devices and neurostimulation implants.

By Nick Paul Taylor • Nov. 30, 2023

GE HealthCare gets 510(k) clearance for algorithm to detect collapsed lungs

The system provides immediate notifications to support the triaging of emergency room patients.

By Nick Paul Taylor • Nov. 29, 2023

3 medtech spinoffs that reshaped the industry in 2023, and what to expect next

GE HealthCare, Johnson & Johnson and Danaher completed transactions this year. Baxter, 3M and Medtronic are now on deck.

By Susan Kelly • Nov. 29, 2023

Advamed applauds Biden’s new actions to strengthen U.S. supply chains

The actions include using the Defense Production Act to enable investment in U.S. manufacturing of essential medicines and medical countermeasures, such as diagnostics.

By Nick Paul Taylor • Nov. 29, 2023

‘Fire, smoke, burns’: FDA warns about new safety risks for Philips CPAP machines

Philips recently filed more than 270 reports of thermal problems related to its DreamStation 2 device from the past three years.

By Elise Reuter • Nov. 28, 2023

Orthofix hires new CEO, 2 months after former leaders ousted

Massimo Calafiore is expected to join the spine and orthopedic device maker in early 2024 from Italy-based LimaCorporate.

By Susan Kelly • Nov. 28, 2023

Unomedical recall of infusion sets tagged as Class I by FDA

The company notified Tandem Diabetes Care, its sole consignee, in October of the risk for infusion sets to detach from insulin pumps, disrupting insulin delivery.

By Nick Paul Taylor • Nov. 28, 2023

Medtronic to chase Boston Scientific, Abbott in left atrial appendage closure market

The medtech giant acquired the Penditure LAA exclusion system in August from Miami-based medical device incubator Syntheon.

By Susan Kelly • Updated Dec. 6, 2023

Roundup: Top medtech companies cut jobs in 2023

Johnson & Johnson, Medtronic and Abbott were among the top companies to announce layoffs this year as the industry implemented cost-cutting measures.

By Ricky Zipp • Nov. 27, 2023

Why medical device companies are worried about the EPA’s planned sterilization regs

The EPA is expected to finalize new regulations in March that would limit ethylene oxide emissions from companies that sterilize medical devices.

By Elise Reuter , Shaun Lucas • Nov. 27, 2023

FDA withdraws from Global Harmonization Working Party

The agency has become “concerned with the divergent harmonization efforts for medical devices” and will focus on working with the International Medical Device Regulators Forum going forward.

By Elise Reuter • Nov. 27, 2023